SGLT2 Inhibitors and Effects on Hematopoiesis, Inflammation and Metabolic Markers

Clinical trial NCT05408936 · UNKNOWN

Trial details

NCT number: NCT05408936
Sponsor: University of Patras
Status: UNKNOWN
Study type: OBSERVATIONAL

Diabetes Mellitus, Type 2

Start date: 2022-06-03
Primary completion: 2023-12-01
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.